Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

TherapeuticsMD Inc (NASDAQ:TXMD)

6.48
Delayed Data
As of Dec 14
 -0.21 / -3.14%
Today’s Change
3.50
Today|||52-Week Range
8.30
+12.31%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Revenue and IncomeNet Revenues4.5M4.0M4.3M4.4M
 
 
 
 
 
Cost of Goods Sold709.7K659.6K681.7K700.8K
 
 
 
 
 
Depreciation And Amortization48.1K49.7K53.2K54.1K
 
 
 
 
 
 
Operating ExpensesGross Income3.7M3.3M3.5M3.7M
 
 
 
 
 
General Expenses26.7M24.6M23.3M18.5M
 
 
 
 
 
Research And Development10.3M7.7M8.7M6.4M
 
 
 
 
 
Total Operating Expenses27.4M25.3M24.1M19.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-22.9M-21.3M-19.8M-14.8M
 
 
 
 
 
Other Expenses101.4K126.0K149.1K167.3K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-22.8M-21.2M-19.7M-14.7M
 
 
 
 
 
Net Income-22.8M-21.2M-19.7M-14.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS196.6M197.8M203.4M207.9M
 
 
 
 
 
Shares To Calculate EPS Diluted196.6M197.8M203.4M207.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.12-$0.11-$0.10-$0.07
 
 
 
 
 
EPS Diluted-$0.12-$0.11-$0.10-$0.07